Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05154487
Title A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors GOG Foundation
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST